Expert Opinion on Investigational Drugs, Volume 32, Issue 12 (2023)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Investigational Drugs, Volume 32, Issue 12 (2023)

See all volumes and issues
Vol 33, 2024 Volume 32, 2023 Vol 31, 2022 Vol 30, 2021 Vol 29, 2020 Vol 28, 2019 Vol 27, 2018 Vol 26, 2017 Vol 25, 2016 Vol 24, 2015 Vol 23, 2014 Vol 22, 2013 Vol 21, 2012 Vol 20, 2011 Vol 19, 2010 Vol 18, 2009 Vol 17, 2008 Vol 16, 2007 Vol 15, 2006 Vol 14, 2005 Vol 13, 2004 Vol 12, 2003 Vol 11, 2002 Vol 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994
Download citations Download PDFs Download issue

Drug Evaluation

Review Article
Upamostat: a serine protease inhibitor for antiviral, gastrointestinal, and anticancer indications
TF. Plasse, R. Fathi, C. Fehrmann & GA. McComsey
Pages: 1095-1103
Published online: 28 Dec 2023
AbstractforUpamostat: a serine protease inhibitor for antiviral, gastrointestinal, and anticancer indications | Full Text | References | PDF (831.1 KB) | EPUB
  • 122 Views
  • 0 CrossRef citations
  • 0Altmetric

Special Report

Report
Bruton tyrosine kinase inhibitors: can they be optimized for the treatment of neuroinflammatory disorders?
Andrea Visentin, Marco Puthenparampil & Chiara Briani
Pages: 1105-1111
Published online: 28 Dec 2023
AbstractforBruton tyrosine kinase inhibitors: can they be optimized for the treatment of neuroinflammatory disorders? | Full Text | References | PDF (1.2 MB) | EPUB
  • 179 Views
  • 0 CrossRef citations
  • 0Altmetric
Report
Muscarinic M1 and M4 receptor agonists for schizophrenia: promising candidates for the therapeutic arsenal
Brian Dean
Pages: 1113-1121
Published online: 28 Dec 2023
AbstractforMuscarinic M1 and M4 receptor agonists for schizophrenia: promising candidates for the therapeutic arsenal | Full Text | References | PDF (917.3 KB) | EPUB
  • 291 Views
  • 1 CrossRef citations
  • 0Altmetric

Review

Review Article
Experimental drugs for the treatment of idiopathic intracranial hypertension (IIH): shedding light on phase I and II trials
Pavan Khatkar, Jess C Hubbard, Lisa Hill, Alexandra J Sinclair & Susan P Mollan
Pages: 1123-1131
Published online: 28 Dec 2023
AbstractforExperimental drugs for the treatment of idiopathic intracranial hypertension (IIH): shedding light on phase I and II trials | Full Text | References | PDF (685.9 KB) | EPUB | Supplemental
  • 109 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Gene expression inhibitors for the treatment of liver fibrosis: drugs under preclinical and early clinical investigation
Matthias Ocker & Daniel Neureiter
Pages: 1133-1141
Published online: 28 Dec 2023
AbstractforGene expression inhibitors for the treatment of liver fibrosis: drugs under preclinical and early clinical investigation | Full Text | References | PDF (939.4 KB) | EPUB
  • 167 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Anti-inflammatory therapies for acute respiratory distress syndrome
Denise Battaglini, Ida Giorgia Iavarone, Lou’i Al-Husinat, Lorenzo Ball, Chiara Robba, Pedro Leme Silva, Fernanda F. Cruz & Patricia RM Rocco
Pages: 1143-1155
Published online: 28 Dec 2023
AbstractforAnti-inflammatory therapies for acute respiratory distress syndrome | Full Text | References | PDF (881.3 KB) | EPUB
  • 143 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Augmentation of natriuretic peptide (NP) receptor A and B (NPR-A and NPR-B) and cyclic guanosine monophosphate (cGMP) signalling as a therapeutic strategy in heart failure
Ashwin Ajay, Debar Rasoul, Alend Abdullah, Benjamin Lee Wei En, Knievel Mashida, Marwan Al-Munaer, Hanan Ajay, Dileep Duvva, Jean Mathew, Adeoye Adenaya, Gregory Y H Lip & Rajiv Sankaranarayanan
Pages: 1157-1170
Published online: 28 Dec 2023
AbstractforAugmentation of natriuretic peptide (NP) receptor A and B (NPR-A and NPR-B) and cyclic guanosine monophosphate (cGMP) signalling as a therapeutic strategy in heart failure | Full Text | References | PDF (2.4 MB) | EPUB
  • 239 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Inflammation and Huntington’s disease- a neglected therapeutic target?
Sophie E. Field et al.
Review Article | Published online: 17 May 2024
Drugs in preclinical and early clinical development for the treatment of Chagas´s disease: the current status
Fernanda Karoline Vieira da Silva Torchelsen et al.
Review Article | Published online: 14 May 2024
Emerging therapies for overactive bladder: preclinical, phase I and phase II studies
Samantha Gibson et al.
Review Article | Published online: 9 May 2024
Frontotemporal dementia: from genetics to therapeutic approaches
Francesca R. Buccellato et al.
Review Article | Published online: 9 May 2024
Open Access
View all latest articles